![]() |
|
|
Vol. 57, Issue 1, 135-143, January 2000
Department of Physiology, National Taiwan University College of
Medicine, and Department of Neurology, National Taiwan University
Hospital, Taipei, Taiwan (C.-C.K.); and Department of Physiology
(R.-C.H.) and Center of General Education (B.-S.L.), Chang Gung
University School of Medicine, Taoyuan, Taiwan
Diphenhydramine is an H1 histamine receptor antagonist,
yet it also has a clinically useful local anesthetic effect. We found that diphenhydramine inhibits the neuronal Na+ current, and
the inhibition is stronger with more positive holding potentials. The
dissociation constant between diphenhydramine and the inactivated
Na+ channel is ~10 µM, whereas the dissociation
constant between diphenhydramine and the resting channel is more than
300 µM. The local anesthetic effect of diphenhydramine thus is
ascribable to inhibition of Na+ current by selective
binding of the drug to the inactivated channels. Most interestingly,
many other compounds, such as the anti-inflammatory drug diclofenac,
the anticonvulsant drug phenytoin, the antidepressant drug imipramine,
and the anticholinergic drug benztropine, have similar effects on
neuronal Na+ current. There is no apparent common motif in
the chemical structure of these compounds, except that they all contain
two phenyl groups. Molecular modeling further shows that the two
benzene rings in all these drugs have very similar spatial orientations
(stem bond angle, ~110 degrees; center-center distance, ~5 Å). In
contrast, the two phenyl groups in phenylbutazone, a drug that has only a slight effect on Na+ current, are oriented in quite a
different way. These findings strongly suggest that the two phenyl
groups are the key ligands interacting with the channel. Because the
binding counterpart of a benzene ring usually is also a benzene ring,
some aromatic side chain groups of the Na+ channel
presumably are realigned during the gating process to make the very
different affinity to the aforementioned drugs between the inactivated
and the resting channels.
This article has been cited by other articles:
![]() |
N. Lenkey, R. Karoly, J. P. Kiss, B. K. Szasz, E. S. Vizi, and A. Mike The Mechanism of Activity-Dependent Sodium Channel Inhibition by the Antidepressants Fluoxetine and Desipramine Mol. Pharmacol., December 1, 2006; 70(6): 2052 - 2063. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Benjamin, F. Pruthi, S. Olanrewaju, V. I. Ilyin, G. Crumley, E. Kutlina, K. J. Valenzano, and R. M. Woodward State-Dependent Compound Inhibition of Nav1.2 Sodium Channels Using the FLIPR Vm Dye: On-Target and Off-Target Effects of Diverse Pharmacological Agents J Biomol Screen, February 1, 2006; 11(1): 29 - 39. [Abstract] [PDF] |
||||
![]() |
D. R. Riddall, M. J. Leach, and J. Garthwaite A Novel Drug Binding Site on Voltage-Gated Sodium Channels in Rat Brain Mol. Pharmacol., January 1, 2006; 69(1): 278 - 287. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-C. Yang and C.-C. Kuo An Inactivation Stabilizer of the Na+ Channel Acts as an Opportunistic Pore Blocker Modulated by External Na+ J. Gen. Physiol., April 25, 2005; 125(5): 465 - 481. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. De Luca, S. Talon, M. De Bellis, J.-F. Desaphy, G. Lentini, F. Corbo, A. Scilimati, C. Franchini, V. Tortorella, and D. C. Camerino Optimal Requirements for High Affinity and Use-Dependent Block of Skeletal Muscle Sodium Channel by N-Benzyl Analogs of Tocainide-Like Compounds Mol. Pharmacol., October 1, 2003; 64(4): 932 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-C. Yang and C.-C. Kuo Inhibition of Na+ Current by Imipramine and Related Compounds: Different Binding Kinetics as an Inactivation Stabilizer and as an Open Channel Blocker Mol. Pharmacol., November 1, 2002; 62(5): 1228 - 1237. [Abstract] [Full Text] [PDF] |
||||